The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models.
2016
S63845 specifically inhibits MCL1 and induces tumour cell death in vitro and in vivo in diverse cancer-derived cell lines with an acceptable safety margin.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
52
References
590
Citations
NaN
KQI